Literature DB >> 8580429

GM1 ganglioside inhibits ischemic release of amino acid neurotransmitters from rat cortex.

J W Phillis1, M H O'Regan.   

Abstract

The effects of a 20 min period of four-vessel occlusion cerebral ischemia followed by reperfusion on glutamate, aspartate, GABA and glycine efflux from the rat cerebral cortex were studied using a cortical cup technique. Cerebral ischemia increased amino acid concentrations in the cortical superfusates. When the cerebral cortices were exposed to topically applied GM1 ganglioside (50 microM) for 40 min prior to ischemia, the evoked efflux of all four amino acids was significantly inhibited. GM1 (1 microM) failed to inhibit amino acid release. The results support the concept that gangliosides have a cerebroprotective action.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8580429     DOI: 10.1097/00001756-199510010-00014

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  4 in total

1.  Metabolomics profiling reveals profound metabolic impairments in mice and patients with Sandhoff disease.

Authors:  Li Ou; Michael J Przybilla; Chester B Whitley
Journal:  Mol Genet Metab       Date:  2018-09-14       Impact factor: 4.797

2.  Activation of cPLA2, PKC, and ERKs in the rat cerebral cortex during ischemia/reperfusion.

Authors:  I Saluja; M H O'Regan; D Song; J W Phillis
Journal:  Neurochem Res       Date:  1999-05       Impact factor: 3.996

3.  Novel Biomarkers of Human GM1 Gangliosidosis Reflect the Clinical Efficacy of Gene Therapy in a Feline Model.

Authors:  Heather L Gray-Edwards; Debra S Regier; Jamie L Shirley; Ashley N Randle; Nouha Salibi; Sarah E Thomas; Yvonne L Latour; Jean Johnston; Gretchen Golas; Annie S Maguire; Amanda R Taylor; Donald C Sorjonen; Victoria J McCurdy; Peter W Christopherson; Allison M Bradbury; Ronald J Beyers; Aime K Johnson; Brandon L Brunson; Nancy R Cox; Henry J Baker; Thomas S Denney; Miguel Sena-Esteves; Cynthia J Tifft; Douglas R Martin
Journal:  Mol Ther       Date:  2017-02-22       Impact factor: 11.454

Review 4.  Limiting neurological damage after stroke: a review of pharmacological treatment options.

Authors:  S J Read; T Hirano; S M Davis; G A Donnan
Journal:  Drugs Aging       Date:  1999-01       Impact factor: 3.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.